AnterogenCoLtd (Korea) Today
| 065660 Stock | KRW 15,200 30.00 0.20% |
Performance0 of 100
| Odds Of DistressLess than 36
|
AnterogenCoLtd is trading at 15200.00 as of the 25th of November 2024, a 0.2 percent decrease since the beginning of the trading day. The stock's open price was 15230.0. AnterogenCoLtd has about a 36 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for AnterogenCoLtd are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of October 2024 and ending today, the 25th of November 2024. Click here to learn more.
,Ltd., a bio-venture company, engages in the research, development, and commercialization of stem cell therapy products using adipose-derived stem cells in South Korea and internationally. ,Ltd. was founded in 2000 and is headquartered in Seoul, South Korea. The company has 7.95 M outstanding shares. More on AnterogenCoLtd
Moving against AnterogenCoLtd Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
AnterogenCoLtd Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. AnterogenCoLtd's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding AnterogenCoLtd or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Pharmaceuticals, Healthcare (View all Sectors) |
AnterogenCoLtd (065660) is traded on KOSDAQ in Korea and employs 6 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 108.41 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AnterogenCoLtd's market, we take the total number of its shares issued and multiply it by AnterogenCoLtd's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. AnterogenCoLtd operates under Healthcare sector and is part of Pharmaceuticals industry. The entity has 7.95 M outstanding shares.
AnterogenCoLtd has accumulated about 6.97 B in cash with (3.05 B) of positive cash flow from operations.
Check AnterogenCoLtd Probability Of Bankruptcy
Ownership AllocationThe market capitalization of AnterogenCoLtd is W108.41 Billion. AnterogenCoLtd retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check AnterogenCoLtd Ownership Details
AnterogenCoLtd Risk Profiles
Although AnterogenCoLtd's alpha and beta are two of the key measurements used to evaluate AnterogenCoLtd's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.61 | |||
| Semi Deviation | 2.13 | |||
| Standard Deviation | 2.23 | |||
| Variance | 4.98 |
AnterogenCoLtd Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in AnterogenCoLtd without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
| All Next | Launch Module |
Other Information on Investing in AnterogenCoLtd Stock
AnterogenCoLtd financial ratios help investors to determine whether AnterogenCoLtd Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AnterogenCoLtd with respect to the benefits of owning AnterogenCoLtd security.